1. Rüdiger M, Rozycki HJ. It's time to reevaluate the Apgar score. JAMA Pediatr. 2020; 174
(4): 321-322 doi: 10.1001/jamapediatrics. 2019.6016 2. Apgar V. A proposal for a new …

1. Rüdiger M, Rozycki HJ. It's time to reevaluate the Apgar score. JAMA Pediatr. 2020; 174
(4): 321-322 doi: 10.1001/jamapediatrics. 2019.6016 2. Apgar V. A proposal for a new …

The proliferationof observational literature on the topic of high-flow nasal cannula (HFNC) as
a therapy for acute viral bronchiolitis is nothing short of remarkable. A brief PubMed search …

High-flow nasal cannula (HFNC): nobody seems to like it, but everyone seems to be using it
as the newest treatment of bronchiolitis. Although supportive care is the mainstay of …

Inpatient bronchiolitis outcomes in North America have changed substantially during the
past 4 decades. Annual deaths associated with bronchiolitis in the United States were once …

Bronchiolitis remains the single most common cause of hospitalization during the first year of
life. 1 Although supportive treatment is the cornerstone of bronchiolitis therapy, with …

High-flow nasal cannula oxygenation for everyone? Not so fast! - Abstract - Europe PMC Sign in
| Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

The American Academy of Pediatrics (AAP) guidelines recommend only supportive therapy
for hospitalised infants with viral bronchiolitis. This includes oxygen therapy for hypoxaemia …

Background: High Flow Nasal Cannula (HFNC) has been widely adopted for escalation of
respiratory support in patients with bronchiolitis; however, its use is dictated by highly variant …

motivating the ongoing effort to identify new therapies that might speed up recovery and
reduce the time infants and families spend in the hospital. However, a familiar pattern in the …